Group 1 - The China Securities Regulatory Commission (CSRC) has approved the initial public offering (IPO) registration of Ningbo Jianxin Superconducting Technology Co., Ltd [1]

Market Overview - The Shanghai Composite Index closed at 3940.95 points, up 0.53%, with a trading volume of 773.9 billion yuan [1] - The Shenzhen Component Index closed at 13486.42 points, up 0.88%, with a trading volume of 1106.34 billion yuan [1] - The ChiNext Index closed at 3229.58 points, up 0.77%, with a trading volume of 508.985 billion yuan [1] - The total trading volume of both markets was 1880.24 billion yuan, a decrease of 19.647 billion yuan compared to the previous trading day [1] Sector Performance - Strong sectors included defense, electronics, construction materials, light manufacturing, machinery, environmental protection, chemicals, and computers [2] - Concepts such as commercial aerospace, satellite internet, 6G, and nuclear pollution prevention showed active performance [2] - Weak sectors included agriculture, precious metals, coal, insurance, and banking [2] Stock Performance - A total of 3989 stocks rose, while 1004 stocks fell, with 173 stocks remaining flat and 13 stocks suspended [2] - 86 stocks hit the daily limit up, while 6 stocks hit the daily limit down [2] Fund Flow - The net inflow of main funds in the Shanghai and Shenzhen markets was 3.81 billion yuan, with the ChiNext seeing a net inflow of 5.12 billion yuan [5] - The electronic sector had the highest net inflow of 4.916 billion yuan, followed by power equipment and defense industries [5] - The chemical sector experienced the largest net outflow of 1.577 billion yuan, along with pharmaceuticals and transportation [5] Individual Stock Highlights - 104 stocks received net inflows exceeding 1 billion yuan, with Demingli leading at 955 million yuan [6] - The top net outflow stock was Xinyi Sheng, with a net outflow of 928 million yuan [10] - Institutional investors net bought 21 stocks, with Tianyin Electromechanical receiving the highest net purchase of approximately 496 million yuan [13]

Market Overview - The Shanghai Composite Index rose by 0.53% on December 24, with 26 out of the 28 sectors experiencing gains, led by the defense and electronics sectors, which increased by 2.88% and 2.12% respectively [1] - The pharmaceutical and biological sector saw a modest increase of 0.24% [1] - The agriculture, forestry, animal husbandry, and fishery sectors, along with coal, were the worst performers, declining by 0.85% and 0.70% respectively [1] Capital Flow Analysis - The net inflow of capital in the two markets reached 10.37 billion yuan, with 17 sectors experiencing net inflows [1] - The electronics sector had the highest net inflow, totaling 8.68 billion yuan, coinciding with its 2.12% increase [1] - The power equipment sector also performed well, with a 1.03% increase and a net inflow of 3.76 billion yuan [1] - Conversely, 14 sectors experienced net outflows, with the non-ferrous metals sector leading with a net outflow of 1.635 billion yuan, followed by the basic chemicals sector with 1.212 billion yuan [1] Pharmaceutical and Biological Sector - The pharmaceutical and biological sector increased by 0.24%, but faced a net outflow of 1.141 billion yuan [2] - Out of 479 stocks in this sector, 320 rose while 134 fell, with one stock hitting the daily limit down [2] - The top three stocks with significant net inflows included C Jianxin with 690 million yuan, followed by Hanyu Pharmaceutical and Innovation Medical with 134 million yuan and 68.69 million yuan respectively [2] - The sector's outflow leaders included Hainan Haiyao with a net outflow of 280 million yuan, followed by Heng Rui Pharmaceutical and Luyan Pharmaceutical with 180 million yuan and 136.53 million yuan respectively [4]

Group 1 - The core point of the article is the listing of Jianxin Superconductor on the Shanghai Stock Exchange today, with an issue price of 18.58 yuan per share and a price-to-earnings ratio of 61.97 times [2][1]. - Jianxin Superconductor's stock code is 688805, and it is listed on the Sci-Tech Innovation Board [2]. - New Guangyi and Shaanxi Tourism have announced the results of their online lottery for stock subscriptions today [1][3]. Group 2 - New Guangyi has a total of 30,085 winning lottery numbers, with each winning number allowing the subscription of 500 shares [4]. - The winning numbers for New Guangyi include specific last digits, such as 6253 for the last four digits and various combinations for the last five and six digits [5]. - Shaanxi Tourism has a total of 38,666 winning lottery numbers, with each winning number also allowing the subscription of 500 shares [4]. - The winning numbers for Shaanxi Tourism include specific last digits, such as 1011 for the last four digits and various combinations for the last five, seven, and nine digits [6].

Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. successfully listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, becoming the first company to achieve "zero liquid helium" superconducting technology in the A-share market [1][2]. Company Overview - Jianxin Superconducting, established in 2013 and headquartered in Cixi High-tech Industrial Development Zone, focuses on the R&D, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI core components [4][7]. - The company has developed a unique all-solid-state conduction cooling technology, achieving a fully helium-free superconducting magnet, with its 1.5T helium-free superconducting magnet already in global commercial application [4][7]. Market Position - As of 2024, Jianxin Superconducting holds a global market share of approximately 4.2%, ranking fifth globally and second among domestic companies, only behind United Imaging Healthcare [7][9]. - The company’s clients for the 1.5T helium-free superconducting magnet include major players such as Wandong Medical, Fujifilm Group, GE Healthcare, and others [7]. Financial Performance - From 2022 to 2025, Jianxin Superconducting's R&D expenses were 20.33 million, 24.42 million, 27.65 million, and 16.75 million yuan respectively [8]. - The company's revenue increased from 359 million yuan in 2022 to 425 million yuan in 2024, with a net profit attributable to shareholders rising from 30.85 million yuan to 50.27 million yuan during the same period [12]. - For the first three quarters of 2025, the company achieved revenue of 393 million yuan, a year-on-year increase of 37.34%, and a net profit of 47.62 million yuan, up 38.54% year-on-year [12]. Industry Trends - The global MRI equipment market is projected to grow from 7.5 billion USD in 2015 to 11.1 billion USD in 2024, with expectations to reach 14.89 billion USD by 2030 [11]. - The cancellation of configuration management for 1.5T and above MRI equipment by the National Health Commission in 2023 is expected to drive the penetration of these devices into the market [11]. - The company is focusing on the development of 3.0T helium-free superconducting magnets, which are anticipated to be a major research direction in the coming years [11].

Core Insights - The core viewpoint of the articles emphasizes the importance of domestic production of MRI equipment, particularly focusing on the self-sufficiency of key components like superconducting magnets and permanent magnets, which are crucial for overcoming industry bottlenecks [1][4]. Company Overview - Jianxin Superconducting has achieved significant technological breakthroughs and large-scale manufacturing in core components such as superconducting magnets and permanent magnets, becoming one of the earliest manufacturers in China to produce high-field superconducting magnets on a large scale and the largest global supplier of MRI equipment permanent magnets [1][4]. - The company has developed a diverse product matrix that includes 1.5T zero-evaporation superconducting magnets, 1.5T liquid helium-free superconducting magnets, and 3.0T zero-evaporation superconducting magnets [4]. Market Position and Strategy - The company aims to make MRI scans more affordable, reducing costs from thousands of yuan to hundreds, and has integrated these services into medical insurance, thereby enhancing access to quality healthcare [1][3]. - Jianxin Superconducting has established deep collaborations with leading manufacturers like Wandong Medical and Shenzhen Anke, ensuring stable supply of 1.5T products and gradually increasing supply of 3.0T products to rural hospitals [6]. Technological Innovation - The company has mastered 13 core technologies with independent intellectual property rights, covering areas such as electromagnetic fields, cryogenics, finite element analysis, structural design, intelligent control, and large-scale manufacturing processes [4]. - Jianxin Superconducting has successfully developed the world's first 1.5T liquid helium-free superconducting magnet, which does not require liquid helium and can automatically recover after quenching, making it suitable for emerging markets with limited maintenance capabilities [6][7]. Global Expansion - The company is actively expanding its overseas market presence, with over 50% of its MRI equipment products sold internationally. It has established local service networks in regions like India and Italy to address the affordability and usability issues in international markets [6][7]. - Jianxin Superconducting's global layout and technological innovations are expected to significantly reduce the overseas delivery and maintenance costs of superconducting magnets, thereby supporting leading manufacturers in promoting their products globally [7]. Long-term Vision - The company emphasizes a long-term commitment to technological innovation and market needs, focusing on core business areas while exploring the feasibility of applying superconducting technology in industrial sectors like wind power and power transmission [9]. - Jianxin Superconducting plans to invest in projects aimed at producing 600 sets of liquid helium-free superconducting magnets annually and upgrading high-field superconducting magnet production, reinforcing its commitment to sustainable growth and innovation in the healthcare sector [9].

统计显示，公司本次发行总量为4192.00万股，其中，网上发行量为1341.45万股，发行价格为18.58元/ 股，发行市盈率61.97倍，行业平均市盈率37.19倍，网上发行最终中签率为0.0241683%。公司首发募资 金额为7.79亿元，募资主要投向年产600套无液氦超导磁体项目、年产600套高场强医用超导磁体技改项 目、新型超导磁体研发项目等。（数据宝） （原标题：N健信首日涨212.81% 换手率77.25%） N健信(688805)今日上市，开盘上涨250.00%，截至收盘涨幅回落至212.81%，全天成交量2434.83万股， 成交额16.06亿元，换手率77.25%。 公司主营业务为医用磁共振成像(MRI)设备核心部件的研发、生产和销售。 | 收盘涨跌幅（%） | 首日换手率（%） | 代码 | 简称 | 最新价（元） | 688805 | N健信 | 58.12 | 212.81 | 77.25 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 | ...

Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. (stock code: 688805.SH) was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with a closing price of 58.12 yuan, reflecting a 212.81% increase from the opening price [1] Company Overview - Jianxin Superconducting focuses on the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI equipment [1] - The controlling shareholders are Xu Jianyi, Xu Hui, and Xu Dianbo, who collectively control 59.92% of the voting rights prior to the issuance [1] Shareholding Structure Post-Issue - After the issuance, the controlling shareholders still include Xu Jianyi, Xu Hui, and Xu Dianbo, with their respective holdings reduced to 31.13%, 3.27%, and 3.27% [2] - The total voting rights controlled by these shareholders decreased to 44.94% post-issue [2] Financial Performance - Revenue for Jianxin Superconducting from 2022 to 2024 was 358.93 million yuan, 450.64 million yuan, and 425.50 million yuan, respectively, with net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan [6] - For the first nine months of 2025, the company reported revenue of 393.30 million yuan, a year-on-year increase of 37.34%, and a net profit of 47.62 million yuan, up 38.54% [10] Future Projections - The company expects to achieve revenue between 580 million yuan and 620 million yuan in 2025, representing a growth of 36.31% to 45.71% compared to 2024 [12] - Projected net profit for 2025 is estimated to be between 72 million yuan and 77 million yuan, indicating a growth of 29.07% to 38.03% [12] Fundraising and Investment Plans - Jianxin Superconducting raised a total of 778.87 million yuan from the issuance, with a net amount of 688.64 million yuan after deducting issuance costs [3] - The funds will be allocated to projects including the annual production of 600 sets of helium-free superconducting magnets and the technological transformation of high-field medical superconducting magnets [5]

Core Viewpoint - Jianxin Superconductor officially listed on the Sci-Tech Innovation Board, becoming the 599th company on the board, amidst a surge in new stock listings and significant first-day gains for recent IPOs [2] Group 1: Market Performance - A total of 109 companies have gone public this year, with a first-day gain probability of 100% and an average first-day increase of 257.88% [2] - Among the newly listed Sci-Tech Innovation Board stocks, 17 have averaged a first-day increase of 250.86% [2] - Notable recent IPOs include Moer Thread-U, which saw a first-day increase of over 400%, and Muxi Co., which had a first-day increase of nearly 700% [2] Group 2: Company Overview - Jianxin Superconductor specializes in the R&D, production, and sales of core components for medical MRI equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of MRI equipment costs [3] - The company has developed a comprehensive product matrix in the superconducting field, including various types of superconducting magnets, and has become the leading independent supplier of superconducting magnets in the global MRI industry [4] Group 3: Technological Advancements - Jianxin has closed a 20-year technology gap with international giants in the field of zero-evaporation superconducting technology, achieving mass production of 1.5T zero-evaporation superconducting magnets and breaking the monopoly of European, American, and Japanese manufacturers [4] - The company has transitioned from a follower to a leader in the next-generation helium-free superconducting technology, successfully developing a fully helium-free superconducting magnet, recognized as the "first of its kind" by the Zhejiang Provincial Department of Economy and Information Technology [4] Group 4: Financial Performance - For the first nine months of 2025, the company reported revenue of 393 million yuan, a year-on-year increase of 37.34%, and a net profit of 47.62 million yuan, up 38.54% year-on-year [7] - The company projects revenue for 2025 to be between 580 million and 620 million yuan, representing a year-on-year growth of 36.31% to 45.71%, with an expected net profit of 72 million to 77 million yuan, reflecting a growth of 29.07% to 38.03% [8] Group 5: Research and Development - The company has consistently increased its R&D investment, with expenditures of 20.33 million yuan, 24.42 million yuan, and 27.65 million yuan from 2022 to 2024, resulting in a compound annual growth rate of 16.61% [8] - R&D investment accounted for 5.86% of total revenue over three years, with a rise to 6.65% in the first half of 2025, indicating a commitment to enhancing product and technology development [8]

今日上市新股表现 | 代码 | 简称 | 最新价（元） | 上午收盘涨跌幅（%） | 半日换手率（%） | | --- | --- | --- | --- | --- | | 688805 | N健信 | 66.53 | 258.07 | 53.14 | （文章来源：证券时报网） N健信(688805)今日上市，开盘上涨250.00%，截至上午收盘涨幅扩大至258.07%，半日成交量1674.92万 股，成交额11.26亿元，换手率53.14%。 公司主营业务为医用磁共振成像(MRI)设备核心部件的研发、生产和销售。 统计显示，公司本次发行总量为4192.00万股，其中，网上发行量为1341.45万股，发行价格为18.58元/ 股，发行市盈率61.97倍，行业平均市盈率37.19倍，网上发行最终中签率为0.0241683%。公司首发募资 金额为7.79亿元，募资主要投向年产600套无液氦超导磁体项目、年产600套高场强医用超导磁体技改项 目、新型超导磁体研发项目等。（数据宝） ...